PMID- 12167279 OWN - NLM STAT- MEDLINE DA - 20020808 DCOM- 20020919 LR - 20031114 IS - 0889-2229 (Print) IS - 0889-2229 (Linking) VI - 18 IP - 10 DP - 2002 Jul 1 TI - Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. PG - 715-22 AB - The recombinant envelope gp120 (rgp120) of human immunodeficiency virus (HIV) is a weak immunogen when administered by intramuscular (IM) injection. In the present study, we report that epidermal powder immunization (EPI) elicits robust antibody responses to the rgp120. EPI of mice with a dose 0.2-5 microg of rgp120 protein elicited geometric mean antibody titers that were 18- to 240-fold higher than that elicited by IM injection using a 5.0 microg dose. Targeting antigen to and mobilization of Langerhans cells (LCs) by EPI may explain the enhanced immunogenicity of the rgp120. EPI with rgp120 using sugar and gold particles as carrier resulted in differential antigen entry into the LCs and differential IgG subclass antibody and cellular immune responses. EPI may serve as a useful tool to evaluate vaccine potential of the rgp120 protein. AD - PowderJect Vaccines, Inc., 585 Science Drive, Madison, WI 53711, USA. dexiang_chen@powderject.com FAU - Chen, Dexiang AU - Chen D FAU - Zuleger, C AU - Zuleger C FAU - Chu, Q AU - Chu Q FAU - Maa, Y-F AU - Maa YF FAU - Osorio, J AU - Osorio J FAU - Payne, L G AU - Payne LG LA - eng PT - Journal Article PL - United States TA - AIDS Res Hum Retroviruses JT - AIDS research and human retroviruses JID - 8709376 RN - 0 (AIDS Vaccines) RN - 0 (Carbohydrates) RN - 0 (HIV Antibodies) RN - 0 (HIV Envelope Protein gp120) RN - 0 (Immunoglobulin G) RN - 0 (Powders) RN - 0 (Vaccines, Synthetic) SB - IM SB - X MH - AIDS Vaccines/*immunology MH - Administration, Cutaneous MH - Animals MH - Carbohydrates/*administration & dosage MH - Cell Movement MH - Female MH - HIV Antibodies/blood MH - HIV Envelope Protein gp120/*immunology MH - Immunization/*methods MH - Immunoglobulin G/blood/classification MH - Langerhans Cells/*immunology/pathology MH - Mice MH - Mice, Inbred BALB C MH - Powders MH - T-Lymphocytes, Cytotoxic/immunology MH - Vaccines, Synthetic/*immunology EDAT- 2002/08/09 10:00 MHDA- 2002/09/20 10:01 CRDT- 2002/08/09 10:00 AID - 10.1089/088922202760072348 [doi] PST - ppublish SO - AIDS Res Hum Retroviruses. 2002 Jul 1;18(10):715-22.